41 results
S-4
EX-4.13
KTRA
Kintara Therapeutics Inc
Registration of securities issued in business combination transactions
13 May 24
4:06pm
S-4
EX-4.18
KTRA
Kintara Therapeutics Inc
Registration of securities issued in business combination transactions
13 May 24
4:06pm
S-4
EX-4.16
KTRA
Kintara Therapeutics Inc
Registration of securities issued in business combination transactions
13 May 24
4:06pm
S-4
EX-4.14
KTRA
Kintara Therapeutics Inc
Registration of securities issued in business combination transactions
13 May 24
4:06pm
S-4
EX-4.17
KTRA
Kintara Therapeutics Inc
Registration of securities issued in business combination transactions
13 May 24
4:06pm
8-K
EX-4.2
l65gyf0cxd9jxrofdzvp
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
EX-4.1
vtda5eaei
13 Apr 22
Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:15pm
8-K
EX-4.3
uf22clv
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-4.1
4bv3dz tf6a
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-4.2
hqafv4lgetr
27 Sep 21
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market
9:41pm
8-K
EX-4.1
sxffy38sy4ojwuyn
1 Sep 20
Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million
8:44am
8-K/A
EX-4.3
tdrdcs7yhhhp0u2
15 Aug 19
Delmar Pharmaceuticals Announces Pricing of $6.8 Million Underwritten Public Offering
12:00am